Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Warnke

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacology|December 1, 2007
Antiretroviral drugsDavid Warnke, Jason Barreto, Zelalem Temesgen
Expert Opinion on Pharmacotherapy|July 29, 2006
Current status of antiretroviral therapyZelalem Temesgen, David Warnke, Mary J Kasten
Expert Opinion on Pharmacotherapy|March 12, 2004
Initial antiretroviral therapy in chronically-infected HIV-positive adultsZelalem Temesgen, Francesca Cainelli, David Warnke, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacology|December 1, 2007
Antiretroviral drugsDavid Warnke, Jason Barreto, Zelalem Temesgen
Expert Opinion on Pharmacotherapy|July 29, 2006
Current status of antiretroviral therapyZelalem Temesgen, David Warnke, Mary J Kasten
Expert Opinion on Pharmacotherapy|March 12, 2004
Initial antiretroviral therapy in chronically-infected HIV-positive adultsZelalem Temesgen, Francesca Cainelli, David Warnke, et al.
Pageof 1